Theratechnologies Inc. (TH.TO)
CAD 3.55
(2.01%)
CAD 3.55
(2.01%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 62.12 Million USD | 15.53% |
| 2022 | 53.77 Million USD | 15.5% |
| 2021 | 46.56 Million USD | 18.93% |
| 2020 | 39.15 Million USD | 5.41% |
| 2019 | 37.14 Million USD | 19.32% |
| 2018 | 31.12 Million USD | 22.91% |
| 2017 | 25.32 Million USD | 11.87% |
| 2016 | 22.63 Million USD | 16.28% |
| 2015 | 19.46 Million USD | 421.38% |
| 2014 | 3.73 Million USD | 3.18% |
| 2013 | 3.61 Million USD | -57.76% |
| 2012 | 8.56 Million USD | 53.01% |
| 2011 | 5.59 Million USD | -81.82% |
| 2010 | 30.79 Million USD | 86.48% |
| 2009 | 16.51 Million USD | 525.33% |
| 2008 | 2.64 Million USD | -15.73% |
| 2007 | 3.13 Million USD | 90.05% |
| 2006 | 1.64 Million USD | -89.98% |
| 2005 | 16.46 Million USD | 521.4% |
| 2004 | 2.64 Million USD | -33.87% |
| 2003 | 4 Million USD | -53.26% |
| 2002 | 8.57 Million USD | 216.55% |
| 2001 | 2.7 Million USD | 272.49% |
| 2000 | 726.9 Thousand USD | -10.8% |
| 1999 | 814.91 Thousand USD | 56.46% |
| 1998 | 520.83 Thousand USD | 30.21% |
| 1997 | 399.99 Thousand USD | 79.67% |
| 1996 | 222.63 Thousand USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 17.47 Million USD | 59.35% |
| 2024 Q1 | 10.96 Million USD | -40.37% |
| 2024 Q3 | 18.07 Million USD | 3.49% |
| 2023 FY | 62.12 Million USD | 15.53% |
| 2023 Q4 | 18.38 Million USD | 15.72% |
| 2023 Q2 | 12.64 Million USD | -16.92% |
| 2023 Q1 | 15.21 Million USD | -1.91% |
| 2023 Q3 | 15.88 Million USD | 25.7% |
| 2022 Q4 | 15.51 Million USD | -0.05% |
| 2022 Q3 | 15.51 Million USD | 50.83% |
| 2022 Q2 | 10.28 Million USD | -17.41% |
| 2022 FY | 53.77 Million USD | 15.5% |
| 2022 Q1 | 12.45 Million USD | 0.93% |
| 2021 Q3 | 12.34 Million USD | 4.18% |
| 2021 FY | 46.56 Million USD | 18.93% |
| 2021 Q4 | 12.34 Million USD | -0.04% |
| 2021 Q1 | 10.01 Million USD | -19.67% |
| 2021 Q2 | 11.85 Million USD | 18.31% |
| 2020 Q2 | 9.78 Million USD | 9.2% |
| 2020 Q1 | 8.95 Million USD | -4.81% |
| 2020 FY | 39.15 Million USD | 5.41% |
| 2020 Q4 | 12.47 Million USD | 57.13% |
| 2020 Q3 | 7.93 Million USD | -18.85% |
| 2019 Q4 | 9.41 Million USD | -2.72% |
| 2019 Q2 | 9.02 Million USD | -0.08% |
| 2019 Q1 | 9.03 Million USD | 4.95% |
| 2019 FY | 37.14 Million USD | 19.32% |
| 2019 Q3 | 9.67 Million USD | 7.2% |
| 2018 Q4 | 8.6 Million USD | -3.99% |
| 2018 FY | 31.12 Million USD | 22.91% |
| 2018 Q1 | 6.31 Million USD | -5.61% |
| 2018 Q2 | 7.39 Million USD | 17.05% |
| 2018 Q3 | 8.96 Million USD | 21.18% |
| 2017 Q1 | 5.29 Million USD | -9.01% |
| 2017 FY | 25.32 Million USD | 11.87% |
| 2017 Q4 | 6.69 Million USD | -1.26% |
| 2017 Q3 | 6.77 Million USD | 14.53% |
| 2017 Q2 | 5.91 Million USD | 11.79% |
| 2016 FY | 22.63 Million USD | 16.28% |
| 2016 Q1 | 5.44 Million USD | -5.17% |
| 2016 Q2 | 5.65 Million USD | 3.84% |
| 2016 Q3 | 5.55 Million USD | -1.71% |
| 2016 Q4 | 5.81 Million USD | 4.78% |
| 2015 Q2 | 5.11 Million CAD | 62.97% |
| 2015 Q1 | 3.14 Million USD | 85.41% |
| 2015 Q4 | 5.73 Million USD | -3.68% |
| 2015 FY | 19.46 Million USD | 421.38% |
| 2015 Q3 | 5.95 Million USD | 16.38% |
| 2014 FY | 3.73 Million USD | 3.18% |
| 2014 Q4 | 1.69 Million USD | 985.61% |
| 2014 Q3 | -191.29 Thousand USD | -108.72% |
| 2014 Q2 | 2.19 Million USD | 5090.37% |
| 2014 Q1 | 42.24 Thousand USD | -30.35% |
| 2013 FY | 3.61 Million USD | -57.76% |
| 2013 Q2 | 1.22 Million USD | 11.18% |
| 2013 Q4 | 60.64 Thousand USD | -95.28% |
| 2013 Q1 | 1.1 Million USD | -57.37% |
| 2013 Q3 | 1.28 Million USD | 4.56% |
| 2012 Q4 | 2.59 Million USD | 21.5% |
| 2012 FY | 8.56 Million USD | 53.01% |
| 2012 Q3 | 2.13 Million USD | 11.91% |
| 2012 Q2 | 1.9 Million USD | 2.26% |
| 2012 Q1 | 1.86 Million USD | -12.77% |
| 2011 Q3 | 1.57 Million USD | 67.5% |
| 2011 Q2 | 942.82 Thousand USD | -0.1% |
| 2011 Q1 | 943.76 Thousand USD | -96.38% |
| 2011 FY | 5.59 Million USD | -81.82% |
| 2011 Q4 | 2.13 Million USD | 35.29% |
| 2010 Q4 | 26.05 Million USD | 1629.93% |
| 2010 Q3 | 1.5 Million USD | -7.45% |
| 2010 Q2 | 1.62 Million USD | -0.38% |
| 2010 Q1 | 1.63 Million USD | -23.48% |
| 2010 FY | 30.79 Million USD | 86.48% |
| 2009 Q3 | 11.5 Million USD | 630.38% |
| 2009 Q2 | 1.57 Million USD | 39.65% |
| 2009 FY | 16.51 Million USD | 525.33% |
| 2009 Q4 | 2.13 Million USD | -81.44% |
| 2009 Q1 | 1.12 Million USD | 83.11% |
| 2008 Q4 | 615.99 Thousand CAD | -13.24% |
| 2008 Q2 | 710.99 Thousand CAD | 18.7% |
| 2008 Q1 | 599 Thousand CAD | -53.71% |
| 2008 FY | 2.64 Million USD | -15.73% |
| 2008 Q3 | 709.99 Thousand CAD | -0.14% |
| 2007 Q4 | 1.29 Million CAD | 72.99% |
| 2007 Q2 | 799.99 Thousand CAD | 178.75% |
| 2007 FY | 3.13 Million USD | 90.05% |
| 2007 Q1 | 286.99 Thousand CAD | -21.8% |
| 2007 Q3 | 747.99 Thousand CAD | -6.5% |
| 2006 Q3 | 411.99 Thousand CAD | 10199.98% |
| 2006 FY | 1.64 Million USD | -89.98% |
| 2006 Q1 | 474.99 Thousand CAD | 48.9% |
| 2006 Q2 | 4000.00 CAD | -99.16% |
| 2006 Q4 | 366.99 Thousand CAD | -10.92% |
| 2005 FY | 16.46 Million USD | 521.4% |
| 2005 Q4 | 319 Thousand CAD | -7.36% |
| 2005 Q3 | 344.34 Thousand USD | -45.43% |
| 2005 Q2 | 630.99 Thousand CAD | -95.82% |
| 2005 Q1 | 15.1 Million CAD | 2902.39% |
| 2004 FY | 2.64 Million USD | -33.87% |
| 2004 Q4 | 503 Thousand CAD | 12.87% |
| 2004 Q3 | 445.65 Thousand USD | -43.01% |
| 2004 Q1 | 778.99 Thousand CAD | -13.15% |
| 2004 Q2 | 781.99 Thousand CAD | 0.39% |
| 2003 FY | 4 Million USD | -53.26% |
| 2003 Q4 | 896.99 Thousand CAD | -4.68% |
| 2003 Q3 | 940.99 Thousand CAD | -8.46% |
| 2003 Q2 | 1.02 Million CAD | -9.82% |
| 2003 Q1 | 1.13 Million CAD | -5.47% |
| 2002 Q1 | - CAD | -100.0% |
| 2002 Q3 | 1.38 Million CAD | -3.83% |
| 2002 Q4 | 1.2 Million CAD | -12.67% |
| 2002 FY | 8.57 Million USD | 216.55% |
| 2002 Q2 | 1.43 Million CAD | 0.0% |
| 2001 FY | 2.7 Million USD | 272.49% |
| 2001 Q4 | 2.6 Million CAD | 260598.4% |
| 2001 Q3 | 1000.00 CAD | -94.31% |
| 2001 Q2 | 17.56 Thousand CAD | -79.08% |
| 2001 Q1 | 83.95 Thousand CAD | 110.89% |
| 2000 FY | 726.9 Thousand USD | -10.8% |
| 2000 Q1 | 275.66 Thousand CAD | 89.04% |
| 2000 Q2 | 200.22 Thousand USD | -27.37% |
| 2000 Q3 | 169.05 Thousand USD | -15.56% |
| 2000 Q4 | 39.8 Thousand CAD | -76.45% |
| 1999 Q4 | 145.82 Thousand USD | -45.52% |
| 1999 Q2 | 67.82 Thousand USD | -66.09% |
| 1999 Q1 | 199.99 Thousand USD | -2.18% |
| 1999 FY | 814.91 Thousand USD | 56.46% |
| 1999 Q3 | 267.63 Thousand USD | 294.63% |
| 1998 FY | 520.83 Thousand USD | 30.21% |
| 1998 Q4 | 204.45 Thousand USD | 61.56% |
| 1998 Q1 | 99.99 Thousand USD | -50.0% |
| 1998 Q3 | 126.55 Thousand USD | 84.33% |
| 1998 Q2 | 68.65 Thousand USD | -31.35% |
| 1997 Q1 | 99.99 Thousand USD | 0.0% |
| 1997 FY | 399.99 Thousand USD | 79.67% |
| 1997 Q2 | 199.99 Thousand USD | 100.0% |
| 1997 Q3 | 99.99 Thousand USD | -50.0% |
| 1997 Q4 | 199.99 Thousand USD | 100.0% |
| 1996 FY | 222.63 Thousand USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Aurora Cannabis Inc. | 131.46 Million CAD | 52.739% |
| Avicanna Inc. | 6.65 Million CAD | -833.051% |
| Avant Brands Inc. | 12.43 Million CAD | -399.751% |
| Cardiol Therapeutics Inc. | -248.35 Thousand CAD | 25116.207% |
| Crescita Therapeutics Inc. | 10.36 Million CAD | -499.469% |
| Knight Therapeutics Inc. | 152.65 Million CAD | 59.3% |
| MediPharm Labs Corp. | 5.85 Million CAD | -961.127% |
| OrganiGram Holdings Inc. | 35.07 Million CAD | -77.141% |
| Canopy Growth Corporation | 80.88 Million CAD | 23.186% |
| Willow Biosciences Inc. | -659 Thousand CAD | 9527.769% |
| Auxly Cannabis Group Inc. | 21.27 Million CAD | -192.001% |